We Are Formosa Medical Group
Formosa Medical Group is a Hong Kong–based company focused on AI-enabled reproductive medicine and IVF decision support.
By combining reproductive medicine expertise, AI research, and healthcare business experience, Formosa aims to build the infrastructure layer for IVF in Asia, delivering real-world, scalable tools to clinics and hospitals.
IVF Needs to Be More Predictable and Scalable
IVF outcomes still vary widely across physicians and centers, as embryo grading and treatment planning remain largely experience-based.
Clinics face staffing constraints, rising patient expectations, and economic pressure, and need objective, standardized tools to support decision-making and patient communication.
An AI Engine from Embryo Imaging to Clinical Decisions
Formosa is building an IVF AI platform that:
Uses 3D embryo imaging models to deliver objective, standardized embryo quality scores.
Integrates patient profiles and treatment protocols to generate personalized outcome predictions and risk insights.
Delivers these capabilities through clinic-friendly software that fits into existing IVF workflows, rather than forcing clinics to redesign their processes around AI.
Team & Advisors
The core team brings together expertise in AI, reproductive medicine, and healthcare business:
Deep learning engineers, data scientists, and product managers focused on building robust, deployable software tools.
Senior IVF clinicians who co-design the products and oversee clinical validation.
Background in medical imaging AI and reproductive medicine, with experience in leading AI commercialization and IP strategy.
IVF AI Product Suite
Formosa is building two core IVF product lines:
1. AI-based Embryo Scoring & Selection
2. IVF Clinical Decision Support & Outcome Prediction
These products share a common data and model foundation, enabling future expansion into broader fertility and women’s health applications.
AI-based Embryo Scoring & Selection
Uses 3D embryo imaging and deep learning algorithms to generate standardized embryo quality scores and risk indicators.
Integrates with existing lab imaging setups and workflows to minimize disruption.
Aims to improve cumulative live birth rates while reducing unnecessary cycles and costs.
IVF Clinical Decision Support & Outcome Prediction
Integrates patient age, hormone profiles, prior cycles, and protocol choices to provide personalized success-rate predictions.
Supports physicians in designing treatment strategies and communicating options with patients using transparent, data-driven insights.
Delivers visual reports that help patients understand trade-offs and expected outcomes.
Market Opportunity
Global IVF cycles and spending are expected to grow strongly over the coming decade, with Asia showing particularly robust demand due to demographic and lifestyle shifts.
Yet clinical workflows and decision tools remain largely traditional, positioning Formosa at the intersection of strong market demand and technology upgrade needs.